Efficacy of concurrent chemoradiotherapy plus adjuvant chemotherapy on advanced cervical cancer

Chinese Journal of Cancer

Volumn 29, Issue 11, 2010, Pages 959-963

  Wang, Shun ^a   Zhang, Da Shui ^a   Pan, Tao ^a   Liu, Sha ^a   Wang, Ming Kun ^a  

^a HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Cervical neoplasm; Concurrent chemoradiotherapy; Local control rate; Short term efficacy

Indexed keywords

CISPLATIN; DOCETAXEL; PACLITAXEL;

ADULT; AGED; ANOREXIA; ARTICLE; BONE MARROW DISEASE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NAUSEA; OVERALL SURVIVAL; PATIENT COMPLIANCE; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SURVIVAL RATE; THROMBOCYTE; UTERINE CERVIX CARCINOMA; VOMITING;

EID: 79955865566     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.010.10186     Document Type: Article

References (10)

1. Sorbe B, Bohr L, Karlsson L, et al. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences [J]. Int J Oncol, 2010, 36(2): 371-378.
2. Eifel PJ, Winter K, Morris M, et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01 [J]. J Clin Oncol, 2004, 22(5): 872-880.
3. Sethi TK, Bhalla NK, Jena AN, et al. Magnetic resonance imaging in carcinoma cervix-does it have a prognostic relevance [J]. Cancer Res Ther, 2005, 1(2): 103-107.
4. Miglietta L, Franzone P, Centurioni MG, et al. A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer [J]. Oncology, 2006, 70(1): 19-24.
5. Nagao S, Fujiwara K, Oda T, et al. Combination chemotherapy of docetaxel and carboplatin in advanced or recurrent cervix cancer, A pilot study [J]. Gynecol Oncol, 2005, 96(3): 805-809.
6. Duenas-Gonzalez A, Cetina-Perez L, Onate-Ocana LF, et al. Multimodal treatment of locally advanced cervical cancer [J]. Arch Med Res, 2005, 36(2): 129-135.
7. Green JA, Kirwan JM. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis [J]. Lancet, 2001, 358(9284): 781-786.
8. Lee MY, Wu HG, Kim K, et al. Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as at definitive treatment for squamous cell carcinoma of the uterine cervix [J]. Gynecol Oncol, 2007, 104(1): 95-99.
9. Falkenberg E, Kim RY, Meleths, et al. Low dose rate vs. High Dose rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience [J]. Brachytherapy, 2006, 5(1): 49-55.
10. Abu-Surrah AS, Kettunen M. Platinum group antitumor chemistry: design and development of new anticancer drugs complementary to cisplatin [J]. J Curr Med Chem, 2006, 13(11): 1337-1357.